Sie scheinen eine veraltete Version der Internet Explorers zu verwenden, die von dieser Webseite nicht unterstützt wird. Bitte nutzen Sie einen Browser wie zum Beispiel Microsoft Edge, Chrome, Firefox oder Safari in einer aktuellen Version.


Deutsche Vereinigung Morbus Bechterew e.V. – Bundesverband,

Deutsche Rheuma-Liga Bundesverband e. V.,

Deutsche Gesellschaft für Rheumatologie e.V.,


S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen, Version: 2019.

Leitfaden Axiale Spondyloarthritis 2019, Erstellt von der ASPAT (Austrian Spondyloarthritis task Force).

Feldtkeller, Ernst Prof. Dr., "Entzündliche Wirbelsäulen-Krankheiten (Spondyloarthritiden)", Deutsche Vereinigung Morbus Bechterew e.V. – Bundesverband 2012.

Morbus Bechterew, Faltblatt Deutsche Rheuma-Liga Bundesverband e. V 2020.

Morbus Bechterew Mehr als „nur“ Rückenschmerzen, Faltblatt Deutsche Rheuma-Liga Bundesverband e. V 2016.

Rheuma in Zahlen: Betroffene Menschen in Deutschland.

Amador-Patarroyo et al., “How Does Age at Onset Influence the Outcome of Autoimmune Diseases?”, Autoimmunity Reviews, vol. 2012, pp. 1-8, 2011.

Atlas, Deyo, “Evaluating and Managing Acute Low Back Pain in the Primary Care Setting”, JGIM, vol. 16, pp.120-131, 2001.

Baraliakos et al., “Efficiency of treatment with non-steroidal anti-inflammatory drugs according to currency recommendations in patients with radiographic and non-radiographic axial spondyloarthritis”, Rheumatology, vol. 56, pp. 95-102, 2016.

Boonen et al., “The burden of non-radiographic axial spondyloarthris”, Seminars in Arthritis and Rheumatism, vol. 44, pp. 556-562, 2015.

Diekhoff T, Eshed I, Radny F, et al "Choose wisely: imaging for diagnosis of axial spondyloarthritis", Published Online First: 28 May 2021

Haibel, H., Redeker, I., Zink, A. et al. Gesundheitsversorgung und Krankheitslast bei Personen mit axialer Spondyloarthritis in Deutschland. Z Rheumatol 78, 865–874 (2019).

Hay et al., “The Extent and Characteristics of Diagnostic Delay in axSpA: A Systematic Review”, Keele University School for Primary, Community and Social Care, vol. ii126, pp. 1-2, 2020.

First, Louie, “Targeting inflammatory pathways in axial spondyloarthritis”, Arthritis Research & Therapy, vol. 21, pp. 1-15, 2019.

Mease et al., “Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry”, Arthritis Care & Research, vol. 70, pp. 1661-1670, 2018.

Morrow, “Defining the Difference: What Makes Biologics Unique”, Biotechnology Healthcare, pp. 25-29, 2004.

National Institutes of Health, “Low Back Pain”, vol. 20, pp. 1-24, 2020.

Ortolan et al., “Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort”, Arthritis Research & Therapy, vol. 20, pp. 1-8, 2018.

Poddubnyy D: "Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis", Rheumatology, Volume 59, Issue Supplement_4, October 2020, Pages iv6–iv17

Proft F et al.,"Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa", Seminars in Arthritis and Rheumatism, Volume 50, Issue 5, October 2020, Pages 1015-1021

Redeker I et al., "Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data", Rheumatology, Volume 58, Issue 9, September 2019, Pages 1634–1638

Rubin, “Epidemiology and Risk Factors for Spine Pain”, Neurol Clin, vol. 25, pp. 353-371, 2007.

Rudwaleit et al., “The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection”, Ann Rheum Dis, vol. 68, pp. 777-783, 2009.

Rusman et al., “Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky”, Current Rheumatology Reports, vol. 20:35, pp. 1-12, 2018.

Schmidt, C.O., Günther, KP., Goronzy, J. et al., "Häufigkeiten muskuloskelettaler Symptome und Erkrankungen in der bevölkerungsbezogenen NAKO Gesundheitsstudie", Bundesgesundheitsblatt 63, 415–425 (2020)

Sieper, J., Poddubnyy, D. Pathogenese der Spondyloarthritiden. Z Rheumatol 79, 5–12 (2020).

Sieper J, Poddubnyy D, "Axial spondyloarthritis" Lancet. 2017 Jul 1;390(10089):73-84.

Sieper, Rudwaleit, “Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care”, Ann Rheum Dis, vol. 64, pp. 659-663, 2005.

Sieper et al., “The IL-23--IL-17 pathways as a therapeutic target in axial spondyloarthritis”, Nature Reviews, vol. 15, pp. 747-757, 2019. 

Strand, Singh, “Patient Burden of Axial Spondyloarthritis”, J Clin Rheumatol, vol. 23, pp. 383-391, 2017.

Strand, Singh, “Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease”, Mayo Clinic, vol. 92, pp. 555-564, 2017.

Torgutalp, Poddubnyy, “IL-17 inhibition in axial spondyloarthritis: current and future perspectives”, Expert Opinion on Biological Therapy, vol. 19, pp. 631-641, 2019.

Wadeley et al., “Sleep in ankylosing spondylitis and non-radiographic axial spondyloarthritis: associations with disease activity, gender and mood”, Clinical Rheumatology, vol. 37, pp. 1045-1052, 2018.

Weisman, “Inflammatory Back Pain”, Rheum Dis Clin North Am., vol. 38, pp. 501-512, 2012.

Weisman, “The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10”, Ann Rheum Dis, vol. 72, pp. 369-373, 2013.